Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

840
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
840
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

40
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
40
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

53
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
53
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining the Therapeutic Ceiling of Endovascular Thrombectomy in Large-Core Stroke: Beyond the Limits of ASPECTS.

Stroke·2026
Same author

Association of cytochrome P450 2C19 genotypes with effectiveness of clopidogrel in ischemic stroke by smoking status.

Scientific reports·2026
Same author

AIM: An Advanced Hybrid Inference Model Combining Clinical Rules and Lifelog-Based Learning for Health Risk Prediction.

Life (Basel, Switzerland)·2026
Same author

Estimated Pulse Wave Velocity Predicts Outcomes After Acute Ischemic Stroke: A Multinational Cohort Analysis.

American journal of hypertension·2026
Same author

Values and Preferences of Korean Patients With Facial Palsy: A Cross-Sectional Survey.

Journal of Korean medical science·2026
Same author

Comprehensive Prestroke Risk Factor Control and Functional Outcomes After Acute Ischemic Stroke.

Journal of the American Heart Association·2026
Same journal

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank.

Journal of the American Heart Association·2026
Same journal

Sex-Specific Association Between Socioeconomic Status and Stroke Mortality.

Journal of the American Heart Association·2026
Same journal

Social Determinants of Health and Cardiovascular Disease-Related Outcome Disparities Among Breast Cancer Survivors: A Systematic Review.

Journal of the American Heart Association·2026
Same journal

Graded Associations Between Left Ventricular Ejection Fraction Improvement and Cardiorenal Outcomes in Heart Failure With Improved Ejection Fraction.

Journal of the American Heart Association·2026
Same journal

Early Multimodal Motor Training After Stroke Promotes Motor Recovery and Whole-Brain Structural Remodeling.

Journal of the American Heart Association·2026
Same journal

EAT-Lancet Diet, Plasma Metabolites, and Risk of Peripheral Artery Disease: A Prospective Cohort Study.

Journal of the American Heart Association·2026
See all related articles

Related Experiment Video

Updated: Apr 30, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

14.4K

SVO70 (Optimal Target Low-Density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke): Rationale and

Wookjin Yang1, Tae-Jin Song2, Seong-Ho Koh3

  • 1Department of Neurology Asan Medical Center, University of Ulsan College of Medicine Seoul Korea.

Journal of the American Heart Association
|April 28, 2026
PubMed
Summary
This summary is machine-generated.

This study investigates intensive versus standard lipid-lowering therapy for small vessel occlusion stroke patients. It aims to determine optimal low-density lipoprotein cholesterol targets to reduce major adverse cardiovascular events.

Keywords:
LDL cholesterolcerebral small vessel diseasehydroxymethylglutaryl‐CoA reductase inhibitorsischemic strokesecondary prevention

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

7.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

14.4K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

7.7K

Area of Science:

  • Cardiology
  • Neurology
  • Clinical Trials

Background:

  • Current stroke guidelines lack specific low-density lipoprotein cholesterol (LDL-C) targets for small vessel occlusion (SVO) stroke.
  • Existing lipid-lowering trials often do not differentiate stroke subtypes or focus on SVO, creating an evidence gap.

Purpose of the Study:

  • To evaluate the efficacy of intensive lipid-lowering therapy compared to standard therapy in reducing major adverse cardiovascular events (MACE) in SVO stroke patients.
  • To establish optimal LDL-C targets for managing SVO stroke.

Main Methods:

  • A multicenter, prospective, randomized, open-label, blinded-endpoint trial (SVO70) enrolling adult patients with neuroimaging-confirmed SVO stroke.
  • Participants randomized 1:1 to intensive LDL-C <70 mg/dL or standard LDL-C 90-110 mg/dL.
  • Primary endpoint: MACE (cardiovascular death, stroke, acute coronary syndrome); secondary endpoints include stroke subtypes, cardiovascular death, myocardial infarction, and all-cause death.

Main Results:

  • This section is not applicable as the study is prospective and results are not yet available.

Conclusions:

  • The SVO70 trial is expected to provide crucial data for defining optimal LDL-C targets in SVO stroke management.
  • Findings will inform clinical guidelines and improve patient outcomes for this specific stroke subtype.